GenMark Diagnostics, Inc. - FORM 10-K - EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - March 21, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - GenMark Diagnostics, Inc.Financial_Report.xls
EX-10.18 - SETTLEMENT AND RELEASE AGREEMENT - GenMark Diagnostics, Inc.d270238dex1018.htm
EX-10.21 - FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT - GenMark Diagnostics, Inc.d270238dex1021.htm
EX-10.2 - FIRST AMENDMENT TO LEASE - GenMark Diagnostics, Inc.d270238dex102.htm
EX-10.26 - EXECUTIVE EMPLOYMENT AGREEMENT - GenMark Diagnostics, Inc.d270238dex1026.htm
EX-10.23 - THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT - GenMark Diagnostics, Inc.d270238dex1023.htm
EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP (US) - GenMark Diagnostics, Inc.d270238dex231.htm
EX-23.2 - CONSENT OF DELOITTE LLP (UK) - GenMark Diagnostics, Inc.d270238dex232.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - GenMark Diagnostics, Inc.d270238dex311.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - GenMark Diagnostics, Inc.d270238dex312.htm
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - GenMark Diagnostics, Inc.d270238dex321.htm
10-K - FORM 10-K - GenMark Diagnostics, Inc.d270238d10k.htm
EX-10.22 - SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT - GenMark Diagnostics, Inc.d270238dex1022.htm

Exhibit 32.2

 

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of GenMark Diagnostics, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2011, as filed with the Securities and Exchange Commission (the “Report”), Paul Ross, Chief Financial Officer of the Company, does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief that:

 

  •  

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  •  

The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 20, 2012

 

/s/    PAUL ROSS        

Paul Ross

Chief Financial Officer (principal financial officer)

GenMark Diagnostics, Inc. Reports